辰欣药业：股价连续三日涨幅达20%

Core Viewpoint - The company announced that its stock experienced an abnormal fluctuation, with a cumulative increase of 20% over three consecutive trading days in July 2025, indicating unusual trading activity [1] Company Operations - The company confirmed that its production and operational activities are normal, and there have been no significant changes in the market environment or industry policies [1] - The company has conducted a self-examination and consulted with its controlling shareholder and actual controller, finding no undisclosed significant information [1] Investor Advisory - The company advises investors to be cautious of trading risks in the secondary market and to make rational decisions regarding their investments [1]